Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial.
Fiche publication
Date publication
janvier 2020
Journal
International journal of radiation oncology, biology, physics
Auteurs
Membres identifiés du Cancéropôle Est :
Pr AYAV Ahmet, Pr PEIFFERT Didier
Tous les auteurs :
Durand-Labrunie J, Baumann AS, Ayav A, Laurent V, Boleslawski E, Cattan S, Bogart E, Le Deley MC, Steen V, Lacornerie T, Peiffert D, Mirabel X
Lien Pubmed
Résumé
Liver transplantation is the standard definitive treatment for nonmetastatic hepatocellular carcinoma (HCC). However, less than 5% of patients are ultimately candidates as a result of frequent comorbidities and graft shortage. The aim of this study was to evaluate stereotactic body radiation therapy (SBRT) as an ablative treatment for inoperable HCC.
Référence
Int. J. Radiat. Oncol. Biol. Phys.. 2020 Jan 27;: